FDA approves denosumab for treatment of postmenopausal osteoporosis
The FDA today approved denosumab, an injectable treatment for postmenopausal women with osteoporosis who are at high risk for fractures.
Anti-cancer drug for women weakens bones Updated: 11:14, Tuesday February 7, 2012 A drug tipped for widespread use to prevent breast cancer in post-menopausal women also accelerates loss of bone density, thus potentially boosting the risk of fractures.